Veracyte Q3 Revenues Spike 75 Percent | GenomeWeb

NEW YORK (GenomeWeb) – Veracyte reported after the close of the market on Thursday a 75 percent jump in revenues for the third quarter.

The South San Francisco, Calif.-based firm reported $9.8 million in revenues for the three months ended Sept. 30, up from $5.6 million in the year-ago quarter, and matching the consensus Wall Street estimate.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.